Fabry Disease in Women: Genetic Basis, Available Biomarkers, and Clinical Manifestations
Fabry Disease (FD) is a rare lysosomal storage disorder caused by mutations in the <i>GLA</i> gene on the X chromosome, leading to a deficiency in α-galactosidase A (AGAL) enzyme activity. This leads to the accumulation of glycosphingolipids, primarily globotriaosylceramide (Gb3), in vit...
Main Authors: | Raafiah Izhar, Margherita Borriello, Antonella La Russa, Rossella Di Paola, Ananya De, Giovambattista Capasso, Diego Ingrosso, Alessandra F. Perna, Mariadelina Simeoni |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/15/1/37 |
Similar Items
-
Genotype–Phenotype Correlation in a New Fabry-Disease-Causing Mutation
by: Agnė Čerkauskaitė, et al.
Published: (2019-05-01) -
Fabry Disease in Slovakia: How the Situation Has Changed over 20 Years of Treatment
by: Katarina Jurickova, et al.
Published: (2022-06-01) -
X‐chromosomal inactivation patterns in women with Fabry disease
by: Laura Wagenhäuser, et al.
Published: (2022-09-01) -
An Overview of Molecular Mechanisms in Fabry Disease
by: Federica Amodio, et al.
Published: (2022-10-01) -
X Chromosome Inactivation in Carriers of Fabry Disease: Review and Meta-Analysis
by: Emanuela Viggiano, et al.
Published: (2021-07-01)